Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stable formulations of antibodies to human programmed death receptor PD-1 and related treatments

Stable formulations of antibodies to human programmed death receptor PD-1 and related treatments

US Patent 9220776 · Granted Dec 29, 2015

Estimated economic value: $79,567,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interpreting color in an environment2025
Activity based sorting in collaborative applications2025
Graphics projector for use in a vehicle2025
Risk informed route planner2025
Holographic display calibration2025
Anti-naloxone and anti-naltrexone monoclonal antibodies and methods of productio2025
Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods2023
Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods2023
Sandwich assay design for small molecules2022
Compositions relating to vitamin D2019
Compositions relating to vitamin D2018
Binding partners specific for vitamin D epimers2017